| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frontiers in Nephrology |


* Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York;
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan; and
Division of Nephrology and Hypertension, Cincinnati Childrens Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
Address correspondence to: Dr. Jonathan Barasch, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, NY 10032. Phone: 212-305-1890; Fax: 212-305-3475; E-mail: jmb4{at}columbia.edu
Neutrophil gelatinaseassociated lipocalin (NGAL) is expressed and secreted by immune cells, hepatocytes, and renal tubular cells in various pathologic states. NGAL exerts bacteriostatic effects, which are explained by its ability to capture and deplete siderophores, small iron-binding molecules that are synthesized by certain bacteria as a means of iron acquisition. Consistently, NGAL deficiency in genetically modified mice leads to an increased growth of bacteria. However, growing evidence suggests effects of the protein beyond fighting microorganisms. NGAL acts as a growth and differentiation factor in multiple cell types, including developing and mature renal epithelia, and some of this activity is enhanced in the presence of siderophore:iron complexes. This has led to the hypothesis that eukaryotes might synthesize siderophore-like molecules that bind NGAL. Accordingly, NGAL-mediated iron shuttling between the extracellular and intracellular spaces may explain some of the biologic activities of the protein. Interest in NGAL has been sparked by the observation that NGAL is massively upregulated after renal tubular injury and may participate in limiting kidney damage. This review summarizes the current knowledge about the dual effects of NGAL as a siderophore:iron-binding protein and as a growth factor and examines the role of these effects in renal injury.
This article has been cited by other articles:
![]() |
P. Devarajan Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury Nephrol. Dial. Transplant., December 1, 2008; 23(12): 3737 - 3743. [Full Text] [PDF] |
||||
![]() |
E. Vinuesa, A. Sola, M. Jung, V. Alfaro, and G. Hotter Lipocalin-2-induced renal regeneration depends on cytokines Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1554 - F1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schulz, J. Hansch, K. Kuhn, M. Schlesener, P. Kossmehl, J. R. Nyengaard, N. Wendt, M. Huber, and R. Kreutz Nephron deficit is not required for progressive proteinuria development in the Munich Wistar Fromter rat Physiol Genomics, September 17, 2008; 35(1): 30 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Nickolas, M. J. O'Rourke, J. Yang, M. E. Sise, P. A. Canetta, N. Barasch, C. Buchen, F. Khan, K. Mori, J. Giglio, et al. Sensitivity and Specificity of a Single Emergency Department Measurement of Urinary Neutrophil Gelatinase-Associated Lipocalin for Diagnosing Acute Kidney Injury Ann Intern Med, June 3, 2008; 148(11): 810 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bennett, C. L. Dent, Q. Ma, S. Dastrala, F. Grenier, R. Workman, H. Syed, S. Ali, J. Barasch, and P. Devarajan Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac Surgery: A Prospective Study Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 665 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Grigoryev, M. Liu, H. T. Hassoun, C. Cheadle, K. C. Barnes, and H. Rabb The Local and Systemic Inflammatory Transcriptome after Acute Kidney Injury J. Am. Soc. Nephrol., March 1, 2008; 19(3): 547 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schiffer, R. Bethunaickan, M. Ramanujam, W. Huang, M. Schiffer, H. Tao, M. M. Madaio, E. P. Bottinger, and A. Davidson Activated Renal Macrophages Are Markers of Disease Onset and Disease Remission in Lupus Nephritis J. Immunol., February 1, 2008; 180(3): 1938 - 1947. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673